BRIDGEWAY CAPITAL MANAGEMENT, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,544
-77.6%
106,700
-48.4%
0.00%
-66.7%
Q2 2023$145,517
+52.1%
206,700
+93.7%
0.00%0.0%
Q1 2023$95,699
-55.3%
106,700
+214.7%
0.00%
-40.0%
Q2 2022$214,000
-72.5%
33,900
-63.9%
0.01%
-66.7%
Q1 2022$779,000
+16.4%
93,900
-27.2%
0.02%
+25.0%
Q4 2021$669,000
-22.3%
128,9000.0%0.01%
-25.0%
Q3 2021$861,000
-21.6%
128,9000.0%0.02%
-20.0%
Q2 2021$1,098,000
-21.2%
128,900
+37.9%
0.02%
+5.3%
Q4 2019$1,393,000
+45.4%
93,5000.0%0.02%
+46.2%
Q3 2019$958,000
-3.3%
93,5000.0%0.01%0.0%
Q2 2019$991,000
-24.2%
93,5000.0%0.01%
-18.8%
Q1 2019$1,307,000
+37.6%
93,5000.0%0.02%
+23.1%
Q4 2018$950,000
-15.3%
93,5000.0%0.01%
+18.2%
Q3 2018$1,122,000
-1.7%
93,5000.0%0.01%
-8.3%
Q2 2018$1,141,000
+23.9%
93,5000.0%0.01%
+20.0%
Q1 2018$921,000
-5.7%
93,500
+33.6%
0.01%
-9.1%
Q4 2017$977,000
+26.9%
70,0000.0%0.01%
+22.2%
Q3 2017$770,000
+39.2%
70,0000.0%0.01%
+28.6%
Q2 2017$553,000
+60.8%
70,000
+133.3%
0.01%
+75.0%
Q1 2017$344,000
-17.3%
30,000
-15.9%
0.00%
-20.0%
Q4 2016$416,000
-13.0%
35,6650.0%0.01%
-28.6%
Q3 2016$478,000
+51.7%
35,665
+124.3%
0.01%
+40.0%
Q2 2016$315,00015,9000.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders